Cholesterol drug may have role in treating prostate cancer

Sep 20, 2010

A drug commonly prescribed for people with high cholesterol may also be effective in treating prostate cancer, according to new research by Dr. Xiao-Yan Wen at St. Michael's Hospital.

Rosuvastatin—a statin drug sold as Crestor—suppressed the growth of transplanted human cells in mice.

"Our data provided solid pre-clinical evidence and a strong rationale for clinical trials of statins in the treatment of prostate cancer," said Wen, whose research appears in the September issue of European Urology, the journal of the European Association of Urology.

Prostate cancer is the most common cancer in Canadian men - one in seven men will develop the disease during his lifetime and one in 27 will die from it. Despite improvements in treatments such as surgery, radiation and chemotherapy, many patients still progress to advanced stages.

Recent clinical trials have shown encouraging results regarding the use of angiogenic inhibitors—substances that prevent the growth of blood vessels that feed tumors.

Wen and his colleagues in Canada and China screened 2,000 small molecules in zebrafish embryos with 2,000 small molecules. Seven compounds—four of them statins—slowed or prevented the growth of those blood vessels. They then decided to investigate the cancer-fighting potential of one of those statins, , and found it suppressed the growth of prostate cancer in mice without apparent side effects.

If human trials confirmed that can optimize the benefits of radiation, that would help doctors determine the most effective, less toxic and affordable treatments for their prostate cancer patients.

Explore further: Increased risk for head, neck cancers in patients with diabetes

Provided by St. Michael's Hospital

4 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

Statins Inhibit Inflammation Within Prostate Tumors

Feb 18, 2010

(PhysOrg.com) -- Patients with prostate cancer who regularly use statins to lower their cholesterol may be enjoying a secondary benefit from the drugs: A new study from Duke University Medical Center shows that statins significantly ...

Prostate cancer spurs new nerves

Dec 01, 2008

Prostate cancer – and perhaps other cancers – promotes the growth of new nerves and the branching axons that carry their messages, a finding associated with more aggressive tumors, said researchers from Baylor College ...

Statins alter prostate cancer patients' PSA levels

Apr 28, 2009

Beyond lowering cholesterol, statin medications have been found to have numerous other health benefits, including lowering a healthy man's risk of developing advanced prostate cancer, as well as lowering his prostate-specific ...

Recommended for you

Incomplete HPV vaccination may offer some protection

12 hours ago

Minority women who received the Human Papillomavirus Vaccination (HPV) even after becoming sexually active had lower rates of abnormal Pap test results than those who were never vaccinated. These findings appear in the journal ...

New imaging agent provides better picture of the gut

12 hours ago

A multi-institutional team of researchers has developed a new nanoscale agent for imaging the gastrointestinal (GI) tract. This safe, noninvasive method for assessing the function and properties of the GI tract in real time ...

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

Vaughn
not rated yet Sep 20, 2010
Anybody know what the other 3 statins were?